Franco DeMonte – författare

It is frequently stated that progress in the management of tumors of the brain and spine has not occurred in the past 25 years. Such statements seriously underestimate and misrepresent progress in managing various central nervous system tumors, the tremendous technologic enhancements that have revolutionized the imaging of the tumors and the host organ, the multitude of surgical adjuncts such as computerized imaging guidance and functional mapping of the brain and its tracts that are routinely used in the modern neurosurgical operating room, and the highly conformal delivery of radiation to the tumor mass with remarkable sparing of the surrounding nervous tissue. Underlying these technologic improvements are the changes in philosophy that have resulted in a true multidisciplinary approach. Equally significant is the molecular revolution that is identifying key markers behind the genesis of brain tumors, their proliferation, and their resistance to therapy. These molecular discoveries have ushered in the era of molecular targeted therapy, as first demonstrated by the extraordinary success story in chronic myelogenous leukemia of imatinib (Gleevec). The rational combination of targeted agents will revolutionize the way che- therapy is given, either alone or in conjunction with radiotherapy. Lastly, focused attention to patients’ well-being has emphasized all measures of quality of life, has encouraged greater participation by patients and their caregivers in the decision-making process, and has encouraged the development of a variety of quality-of-life measurement tools to ensure that adverse effects of treatment are recognized and addressed.

It is frequently stated that progress in the management of tumors of the brain and spine has not occurred in the past 25 years. Such statements seriously underestimate and misrepresent progress in managing various central nervous system tumors, the tremendous technologic enhancements that have revolutionized the imaging of the tumors and the host organ, the multitude of surgical adjuncts such as computerized imaging guidance and functional mapping of the brain and its tracts that are routinely used in the modern neurosurgical operating room, and the highly conformal delivery of radiation to the tumor mass with remarkable sparing of the surrounding nervous tissue. Underlying these technologic improvements are the changes in philosophy that have resulted in a true multidisciplinary approach. Equally significant is the molecular revolution that is identifying key markers behind the genesis of brain tumors, their proliferation, and their resistance to therapy. These molecular discoveries have ushered in the era of molecular targeted therapy, as first demonstrated by the extraordinary success story in chronic myelogenous leukemia of imatinib (Gleevec). The rational combination of targeted agents will revolutionize the way che- therapy is given, either alone or in conjunction with radiotherapy. Lastly, focused attention to patients’ well-being has emphasized all measures of quality of life, has encouraged greater participation by patients and their caregivers in the decision-making process, and has encouraged the development of a variety of quality-of-life measurement tools to ensure that adverse effects of treatment are recognized and addressed.

The management of tumors in and adjacent to the skullbase is challenging given the complex and critically important anatomy of the region and the wide diversity of tumor pathologies that may be encountered. To help navigate the complexities of contemporary multidisciplinary management of these patients, Drs. Hanna and DeMonte bring you Comprehensive Management of Skull Base Tumors, a comprehensive guide filled with updated information from authorities around the world.

Comprehensive Management of Skull Base Tumors is divided into three sections consisting of:

general principles site specific surgery tumor specific management

Filled with scientific tables and lavishly illustrated, this text is written with an emphasis on surgery, radiation and chemotherapy, and will appeal to all neurosurgeons, otolaryngologists, plastic surgeons, maxillofacial surgeons, ophthalmologists, medical and radiation oncologists, and radiologists.

The management of tumors in and adjacent to the skullbase is challenging given the complex and critically important anatomy of the region and the wide diversity of tumor pathologies that may be encountered. To help navigate the complexities of contemporary multidisciplinary management of these patients, Drs. Hanna and DeMonte bring you Comprehensive Management of Skull Base Tumors, a comprehensive guide filled with updated information from authorities around the world.

Comprehensive Management of Skull Base Tumors is divided into three sections consisting of:

general principles site specific surgery tumor specific management

Filled with scientific tables and lavishly illustrated, this text is written with an emphasis on surgery, radiation and chemotherapy, and will appeal to all neurosurgeons, otolaryngologists, plastic surgeons, maxillofacial surgeons, ophthalmologists, medical and radiation oncologists, and radiologists.

This issue of the Neurosurgery Clinics, Malignant Tumors of the Skull Base, is Guest Edited by Drs. Orin Bloch and Franco DeMonte. Malignant tumors of the skull base pose significant challenges to the clinician, because of their proximity to critical neurovascular structures. This issue will explore various approaches to the removal of malignant tumors of the skull base, including open surgical approaches and minimally invasive approaches. Other articles in this issue include topics such as craniofacial reconstruction following oncologic resection, temporal bone malignancies, sinonasal carcinomas, and radiotherapy for malignant skull base tumors.

The consummate guide on the contemporary management of complex skull base tumors from renowned multidisciplinary experts!An increased understanding of the biology and molecular characterization of skull base tumors has led to innovative new approaches. Endoscopic tumor resection, surgical reconstruction, and advances in radiation delivery, chemotherapy, and targeted biologic therapy, have greatly expanded treatment options for patients with these challenging tumors. The updated second edition of Comprehensive Management of Skull Base Tumors by master surgeons Ehab Hanna, Franco DeMonte, and an impressive group of global experts reflects expanded knowledge of skull base tumors and evidence-based advances.This generously illustrated second edition is organized into three sections with 42 chapters. Section I features expanded coverage of endonasal skull base anatomy and surgical principles, as well as radiotherapeutic advances such as proton therapy and stereotactic radiation. Section II is focused on site-specific procedures with emphasis on surgical approaches, and Section III focuses on tumor-specific considerations with emphasis on multidisciplinary treatment approaches. Core topics of this thorough book include pathology, genetics, diagnostic considerations, surgical reconstruction, rehabilitation, chemotherapy, functional outcomes, quality of life issues, neurocognitive assessment, and cerebrovascular management.Key Features In-depth discussion of anatomic regions of the cranial base, including surgical anatomy, regional pathology, differential diagnosis, clinical assessment, diagnostic imaging, and surgical approachesIncidence, epidemiology, pathology, staging, multidisciplinary treatment, outcome, and prognosis for a wide range of neoplasms including squamous cell carcinoma, chondrosarcomas, chordomas, meningiomas, schwannomas, paragangliomas, pituitary adenomas, craniopharyngiomas, epidermoids, and fibro-osseous lesionsOutstanding illustrations, surgical and clinical photos, imaging, tables, and videos new to this edition, enhance understanding of complex skull base tumorsThe most comprehensive resource available today on the management and treatment of skull base tumors, this book is essential reading for neurosurgical and otolaryngology residents. It will also benefit surgeons who specialize in oromaxillofacial, craniofacial, and plastic and reconstructive surgery.This book includes complimentary access to a digital copy on https://medone.thieme.com.

Foremost authorities present the milestone text on meningioma management, now in a fully updated Second Edition

Al-Mefty''s Meningiomas, Second Edition is the definitive guide to meningioma diagnosis, treatment, and surgery, and reflects over a decade of major advances in the diagnosis and management of both intracranial and spinal meningiomas since the first edition was published.

Features:

New to this edition: information on molecular biology, natural history and growth rates, the rise of radiosurgery as a viable treatment option, and much more Over 500 high-quality radiographic images and full-color illustrations demonstrate anatomy and surgery In-depth coverage of intraoperative MRI and endoscopic resection Key topics often missing from other meningiomas texts including caseload management, and postoperative quality of life issues

This landmark reference will enhance the precision and surgical skills of every clinician or resident in neurosurgery or neurology.

This volume comprehensively reviews the current literature on temporal bone cancer and the multidisciplinary approaches used to managing these rare tumors. The text will review important medical issues as they specifically relate to  temporal bone cancer such as advanced imaging, pathologic classification, skull base surgery, plastic reconstructive surgery, and advances in osseointegrated implants for hearing restoration. Additional chapters are dedicated to the evaluation and management, diagnostic radiology, surgical planning and techniques, radiotherapy, chemotherapy, and rehabilitation. An emphasis is placed on the multidisciplinary approach required for the optimal care of these rare tumors.Written by leaders in the field, Temporal Bone Cancer will be an invaluable resource for residents and fellows in Otolaryngology, Neurosurgery and Neurotology, and clinicians with interest in the primary tumors of the temporal bone.

This volume comprehensively reviews the current literature on temporal bone cancer and the multidisciplinary approaches used to managing these rare tumors. The text will review important medical issues as they specifically relate to  temporal bone cancer such as advanced imaging, pathologic classification, skull base surgery, plastic reconstructive surgery, and advances in osseointegrated implants for hearing restoration. Additional chapters are dedicated to the evaluation and management, diagnostic radiology, surgical planning and techniques, radiotherapy, chemotherapy, and rehabilitation. An emphasis is placed on the multidisciplinary approach required for the optimal care of these rare tumors.Written by leaders in the field, Temporal Bone Cancer will be an invaluable resource for residents and fellows in Otolaryngology, Neurosurgery and Neurotology, and clinicians with interest in the primary tumors of the temporal bone.

This volume comprehensively reviews the current literature on temporal bone cancer and the multidisciplinary approaches used to managing these rare tumors. The text will review important medical issues as they specifically relate to  temporal bone cancer such as advanced imaging, pathologic classification, skull base surgery, plastic reconstructive surgery, and advances in osseointegrated implants for hearing restoration. Additional chapters are dedicated to the evaluation and management, diagnostic radiology, surgical planning and techniques, radiotherapy, chemotherapy, and rehabilitation. An emphasis is placed on the multidisciplinary approach required for the optimal care of these rare tumors.

Written by leaders in the field, Temporal Bone Cancer will be an invaluable resource for residents and fellows in Otolaryngology, Neurosurgery and Neurotology, and clinicians with interest in the primary tumors of the temporal bone.